ANI Pharmaceuticals Profit Margin 2006-2021 | ANIP
Current and historical gross margin, operating margin and net profit margin for ANI Pharmaceuticals (ANIP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ANI Pharmaceuticals net profit margin as of June 30, 2021 is -8.07%.
|ANI Pharmaceuticals Annual Profit Margins
|ANI Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.